COPYTELE, INC. 10-K

Company

Anixa Biosciences Inc

Filed

February 14, 2011

Period of Report

October 31, 2010

Accession Number

0001157523-11-000826

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →